IMC 14.1% 10.5¢ immuron limited

News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...

  1. 191,623 Posts.
    lightbulb Created with Sketch. 2809

    June 9 (Reuters) - Immuron Ltd (IMC) :

    • US DOD NAVAL MEDICAL RESEARCH CENTER REQUESTS MEETING WITH FDA FOR GUIDANCE ON TWO PHASE 2 TRIALS TO PREVENT ACUTE INFECTIOUS DIARRHEA
    • IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021
    • IMMURON - ONE TRIAL TO FOCUS ON ABILITY OF HYPERIMMUNE PRODUCT TO PROTECT VOLUNTEERS AGAINST MODERATE TO SEVERE CAMPYLOBACTERIOSIS
    • IMMURON - SECOND TRIAL WILL FOCUS ON ETEC INFECTIONS
    • IMMURON LTD - NMRC PLANS TO FILE IND APPLICATION LATER THIS YEAR, COMMENCE PHASE 2 CLINICAL STUDIES DURING H1 2021
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.